User profiles for Claudio Viscoli

Claudio Viscoli

University of Genova, Ospedale Policlinico San Martino, IRCCS per l'Oncologia
Verified email at unige.it
Cited by 42067

Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and …

…, JD Sobel, TC Sorrell, C Viscoli… - Clinical infectious …, 2008 - academic.oup.com
Background. Invasive fungal diseases are important causes of morbidity and mortality. Clarity
and uniformity in defining these infections are important factors in improving the quality of …

Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses …

…, GR Thompson III, JA Vazquez, C Viscoli… - Clinical Infectious …, 2020 - academic.oup.com
Background Invasive fungal diseases (IFDs) remain important causes of morbidity and
mortality. The consensus definitions of the Infectious Diseases Group of the European …

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Importance of Combination …

M Tumbarello, P Viale, C Viscoli… - Clinical infectious …, 2012 - academic.oup.com
Background . The spread of Klebsiella pneumoniae (Kp) strains that produce K. pneumoniae
carbapenemases (KPCs) has become a significant problem, and treatment of infections …

[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

…, J Sinkó, A Skiada, MJGT Vehreschild, C Viscoli… - Clinical Microbiology …, 2018 - Elsevier
The European Society for Clinical Microbiology and Infectious Diseases, the European
Confederation of Medical Mycology and the European Respiratory Society Joint Clinical …

International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical …

…, A Forrest, DR Giacobbe, C Viscoli… - … : The Journal of …, 2019 - Wiley Online Library
The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the
1950s and thus did not undergo contemporary drug development procedures. Their clinical …

[HTML][HTML] ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

…, A Skiada, C Lass-Flörl, T Calandra, C Viscoli… - …, 2017 - ncbi.nlm.nih.gov
The European Conference on Infections in Leukemia (ECIL) provides recommendations for
diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various …

[HTML][HTML] European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European …

…, DM Livermore, M Mikulska, C Viscoli… - …, 2013 - ncbi.nlm.nih.gov
Owing to increasing resistance and the limited arsenal of new antibiotics, especially against
Gram-negative pathogens, carefully designed antibiotic regimens are obligatory for febrile …

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

…, L Ostrosky-Zeichner, J Sobel, C Viscoli… - Clinical infectious …, 2008 - academic.oup.com
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality among
highly immunocompromised patients. Authoritative consensus criteria to diagnose IFD …

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

…, S Ambretti, R Cauda, C Viscoli… - Journal of …, 2015 - academic.oup.com
Objectives Infections caused by Klebsiella pneumoniae (Kp) carbapenemase (KPC)-producing
strains of Kp have become a significant threat in recent years. To assess their outcomes …

[HTML][HTML] Epidemiological trends in nosocomial candidemia in intensive care

…, MP Molinari, R Rosso, FB Pallavicini, C Viscoli - BMC Infectious …, 2006 - Springer
Background Infection represents a frequent complication among patients in Intensive Care
Units (ICUs) and mortality is high. In particular, the incidence of fungal infections, especially …